$Taysha Gene Therapies, Inc.(T

TSHA

12-05 06:35

USTaysha Gene Therapies, Inc.

Side	Price \| Filled	Realized P&L
Sell Close	5.10 50	+222.52% Closed

Taysha Gene Therapies, Inc.

Trade Feed: Who is your favorite trader?

Come to the Trade Feed Topic to find more trading opportunities! Also, please feel free to recommend and introduce fellow Tigers to the "hidden gem traders" that you've discovered!

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Trade Feed Decoder
12-05
Trade Feed Decoder
Analysis of TSHA Trade: This trade demonstrates a high-risk, high-reward strategy typical in biotech stocks, where volatility often stems from clinical trial outcomes or regulatory catalysts. The +222.52% realized gain suggests entry during a lower valuation phase, possibly timed around negative sentiment or pre-catalyst positioning. Selling at $5.1 aligns with profit-taking behavior common in speculative biotech plays, where traders capitalize on momentum shifts rather than long-term fundamentals. The sizable return highlights effective risk management in a sector prone to binary outcomes. However, such gains aren’t representative of average outcomes in this space—position sizing and exit discipline would be critical here. The trade reflects a tactical approach to leveraging volatility while managing exposure to regulatory/clinical risks inherent in gene therapy development.

Leave a comment

{"i18n":{"language":"en_US"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":507355006202328,"tweetId":"507355006202328","gmtCreate":1764887763325,"gmtModify":1764887765902,"author":{"id":4093059716761930,"idStr":"4093059716761930","authorId":4093059716761930,"authorIdStr":"4093059716761930","name":"Jason Thoh","avatar":"https://community-static.tradeup.com/news/59bd64e94d037c3783c62510f3111e22","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":11,"crmLevelSwitch":1,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.11.13","exceedPercentage":"80.40%","individualDisplayEnabled":0},"individualDisplayBadges":[],"fanSize":85,"starInvestorFlag":true,"fullDisclosureFlag":true,"starInvestorFollowerNum":85,"starInvestorOrderShareNum":15,"userFollowInvestorFlag":false,"orderNotificationFlag":false,"ror":191.53,"showRor":true,"winRationPercentage":59.52381,"tradeVolumeEst":0},"themes":[{"themeId":"4e1ab37448a24dd39b7882426fc6fd27","categoryId":"ab3d937a5fd848c08008411a9be702b5","name":"Trade Feed: Who is your favorite trader?","type":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/detail&rndata={\"themeId\":4e1ab37448a24dd39b7882426fc6fd27}&rnconfig={\"headerBarHidden\": true}","description":"Come to the Trade Feed Topic to find more trading opportunities! Also, please feel free to recommend and introduce fellow Tigers to the \"hidden gem traders\" that you've discovered!","image":"https://community-static.tradeup.com/news/e496e574dd744490c7b4f7959f83f5a4"}],"images":[],"coverImages":[],"html":"<html><head></head><body><a href=\"https://ttm.financial/S/TSHA\">$Taysha Gene Therapies, Inc.(TSHA)$&nbsp;</a><a href=\"https://ttm.financial/U/10000000000011061\">@Trade Feed Decoder</a></body></html>","htmlText":"<html><head></head><body><a href=\"https://ttm.financial/S/TSHA\">$Taysha Gene Therapies, Inc.(TSHA)$&nbsp;</a><a href=\"https://ttm.financial/U/10000000000011061\">@Trade Feed Decoder</a></body></html>","text":"$Taysha Gene Therapies, Inc.(TSHA)$ @Trade Feed Decoder","highlighted":1,"essential":1,"paper":1,"likeSize":44,"commentSize":1,"repostSize":27,"favoriteSize":0,"link":"https://ttm.financial/post/507355006202328","repostId":0,"isVote":1,"tweetType":1,"viewCount":1313,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["TSHA"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":true,"orderData":{"uuid":"4093059716761930","orderId":"41416259993734144","kind":"TRADE","symbol":"TSHA","secType":"STK","symbolHtmlTag":"<a href=\"https://ttm.financial/S/TSHA\">$Taysha Gene Therapies, Inc.(TSHA)$&nbsp;</a>","symbolHtmlTagHref":"https://ttm.financial/S/TSHA","symbolName":"Taysha Gene Therapies, Inc.","market":"US","action":"SELL","currency":"USD","symbolLogo":"","showFilledQuantity":true,"nameCN":"Taysha Gene Therapies, Inc.","orderType":"LMT","filledQuantityFinal":50,"avgFillPrice":5.1,"createTime":1764887718,"filledQuantity":"50","filledQuantityScale":"0","openFlag":false,"side":"DEBIT","contractMajorDescription":"Taysha Gene Therapies, Inc.","contractExtraDescription":"TSHA","legs":[],"completedFlag":true,"orderPnl":{"realizedPnlPercent":2.2252,"realizedPnlByAveragePercent":2.3002},"quickOrderFlag":false},"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":["订单分享帖","未分享订单分享帖"],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":17,"optionInvolvedFlag":false,"xxTargetLangEnum":"ORIG"},"commentList":[{"id":507371235463712,"commentId":"507371235463712","gmtCreate":1764891634749,"gmtModify":1764898669706,"authorId":10000000000011060,"author":{"id":10000000000011060,"idStr":"10000000000011061","authorId":10000000000011060,"name":"Trade Feed Decoder","avatar":"https://community-static.tradeup.com/news/4dc8fec78bad5acffbf563bdbc6bc8ed","vip":4,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":507355006202328,"objectIdStr":"507355006202328","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"Analysis of TSHA Trade:  \nThis trade demonstrates a high-risk, high-reward strategy typical in biotech stocks, where volatility often stems from clinical trial outcomes or regulatory catalysts. The +222.52% realized gain suggests entry during a lower valuation phase, possibly timed around negative sentiment or pre-catalyst positioning. Selling at $5.1 aligns with profit-taking behavior common in speculative biotech plays, where traders capitalize on momentum shifts rather than long-term fundamentals. The sizable return highlights effective risk management in a sector prone to binary outcomes. However, such gains aren’t representative of average outcomes in this space—position sizing and exit discipline would be critical here. The trade reflects a tactical approach to leveraging volatility while managing exposure to regulatory/clinical risks inherent in gene therapy development.","text":"Analysis of TSHA Trade:  \nThis trade demonstrates a high-risk, high-reward strategy typical in biotech stocks, where volatility often stems from clinical trial outcomes or regulatory catalysts. The +222.52% realized gain suggests entry during a lower valuation phase, possibly timed around negative sentiment or pre-catalyst positioning. Selling at $5.1 aligns with profit-taking behavior common in speculative biotech plays, where traders capitalize on momentum shifts rather than long-term fundamentals. The sizable return highlights effective risk management in a sector prone to binary outcomes. However, such gains aren’t representative of average outcomes in this space—position sizing and exit discipline would be critical here. The trade reflects a tactical approach to leveraging volatility while managing exposure to regulatory/clinical risks inherent in gene therapy development.","html":"Analysis of TSHA Trade:  \nThis trade demonstrates a high-risk, high-reward strategy typical in biotech stocks, where volatility often stems from clinical trial outcomes or regulatory catalysts. The +222.52% realized gain suggests entry during a lower valuation phase, possibly timed around negative sentiment or pre-catalyst positioning. Selling at $5.1 aligns with profit-taking behavior common in speculative biotech plays, where traders capitalize on momentum shifts rather than long-term fundamentals. The sizable return highlights effective risk management in a sector prone to binary outcomes. However, such gains aren’t representative of average outcomes in this space—position sizing and exit discipline would be critical here. The trade reflects a tactical approach to leveraging volatility while managing exposure to regulatory/clinical risks inherent in gene therapy development.","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"hot","coins":0,"score":0,"disclaimerFlag":true,"disclaimerType":1,"specialCommentTag":"AI_ANALYSE"}],"isCommentEnd":false,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/507355006202328"}